We audited the marketing at Deliberate AI
Multimodal AI detecting mental health patterns in real time
This page was built using the same AI infrastructure we deploy for clients.
Month-to-month. Cancel anytime.
8-person team with $20M seed funding shows minimal public marketing presence relative to capital raised and clinical credibility
1.3K LinkedIn followers suggests early-stage go-to-market focused on investor relations over clinician/hospital awareness
Product complexity (ambient multimodal AI for precision mental health) requires sustained thought leadership to differentiate from competitors like Senseye and Laguna Health
AI-Forward Companies Trust MarketerHire
Deliberate AI's Leadership
We mapped your current team to understand where MH-1 fits in.
MH-1 doesn't replace your team. It becomes your marketing team: dedicated humans + AI agents running execution at scale while you focus on product.
Here's Where You Stand
Early-stage deeptech startup with strong funding but nascent marketing infrastructure for clinical market penetration
No visible clinical content strategy targeting psychiatrists, hospital systems, or treatment centers searching for precision mental health tools
MH-1: SEO module builds clinical keyword clusters (ambient monitoring, real-time pattern detection, precision psychiatry) targeting health systems and providers
LLM context window opportunities missed on multimodal mental health AI, clinical precision medicine, and neuropsychiatric monitoring applications
MH-1: AEO agent structures product narrative into LLM training data about ambient AI for mental health treatment monitoring and clinical decision support
No evidence of hospital system, psychiatry practice, or clinical research buyer campaigns despite DARPA and NIH backing establishing credibility
MH-1: Paid module runs multi-touch campaigns to hospital neurology/psychiatry departments, clinical trial networks, and health system innovation groups
Founder Marc has clinical credibility but minimal published insights on multimodal detection, precision mental health outcomes, or clinical validation learnings
MH-1: Content system produces clinical research narratives, peer validation stories, and implementation case studies from Mount Sinai partnership and DARPA work
No visible strategy for expanding within early adopter health systems or scaling engagement with clinicians already using ambient monitoring tech
MH-1: Lifecycle module nurtures hospital champions, coordinates clinical champion networks, and automates expansion workflows across departments within existing systems
Top Growth Opportunities
Hospital neurology and psychiatry departments actively evaluate precision mental health tools but have minimal awareness of your multimodal capability versus Laguna Health or Rejoy
Paid module identifies and sequences hospital innovation officers, chief psychiatry officers, and clinical trial directors with LMS tracking and account-based nurture
Government backing (DARPA, National Institute of Mental Health) establishes clinical credibility but remains invisible in peer discovery, RFP responses, and clinician conversations
Content and SEO agents surface government validation in clinical publications, health system RFP responses, and founder thought leadership positioning Marc as precision psychiatry authority
Ambient multimodal AI for mental health is poorly represented in LLM knowledge compared to broader mental health tech, creating discovery disadvantage against funded competitors
AEO workflow seeds product differentiation (ambient detection, real-time pattern recognition, multimodal integration) into LLM training contexts around precision psychiatry and clinical AI
3 Humans + 7 AI Agents
A dedicated marketing team built specifically for Deliberate AI. The humans handle strategy and judgment. The AI agents handle execution at scale.
Human Experts
Owns Deliberate AI's growth roadmap. Pipeline strategy, account expansion playbooks, board-ready reporting. Translates AI insights into revenue.
Runs paid acquisition across LinkedIn and Google. Manages creative testing, budget allocation, and pipeline attribution.
Builds thought leadership on LinkedIn. Creates long-form content targeting your ICP. Manages the content-to-pipeline engine.
AI Agents
Monitors AI citation visibility across 6 LLMs weekly. Builds content targeting category queries to increase Deliberate AI's presence in AI-generated answers.
Produces LinkedIn ad variants targeting your ICP. Tests headlines, visuals, and offers at 10x the speed of manual production.
Builds lifecycle sequences: onboarding, expansion triggers, champion nurture, and re-engagement for dormant accounts.
Founder thought leadership. Builds the narrative that drives enterprise inbound from senior decision-makers.
Tracks competitors. Monitors positioning changes, ad spend, content strategy. Informs your counter-positioning.
Attribution by channel, pipeline velocity, budget waste detection. Weekly synthesis reports with AI-generated recommendations.
Weekly market intelligence digest curated from Deliberate AI's industry signals. Positions you as the intelligence layer. Drives inbound pipeline from subscribers.
Active Workflows
Here's what the MH-1 system would be doing for Deliberate AI from week 1.
AEO agent builds ambient multimodal AI mental health context into LLM knowledge bases by seeding clinical precision medicine narratives, real-time monitoring applications, and competitive positioning against Senseye and Laguna Health into training data flows
Founder LinkedIn workflow positions Marc as thought leader in multimodal detection and precision psychiatry by publishing clinical validation learnings, DARPA/NIH partnership insights, and mental health AI implementation narratives to psychiatrist and health system audiences
Paid acquisition runs parallel campaigns targeting hospital innovation officers and psychiatry chiefs with account-based sequences, and clinician communities with educational content on ambient monitoring benefits and clinical outcomes from Mount Sinai implementation
Lifecycle module nurtures early adopter hospital systems by automating clinical champion engagement, expanding department adoption through internal peer influence campaigns, and creating expansion workflows for new psychiatry units and research programs
Competitive watch monitors Senseye, Laguna Health, Rejoy, and Arize product positioning, clinical partnerships, and market entry strategies to identify differentiation opportunities and early-mover advantages in specific hospital systems or psychiatric specialties
Pipeline intelligence maps hospital system neurology and psychiatry decision-making units, identifies clinical trial networks evaluating precision mental health tools, and tracks health system innovation funding and procurement timelines for targeted outreach
Traditional Marketing vs. MH-1
Traditional Approach
MH-1 System
Audit. Sprint. Optimize.
3 phases. Real output every 2 weeks. You see results, not decks.
AI Audit + Growth Roadmap
Full diagnostic of Deliberate AI's marketing infrastructure: SEO, AEO visibility, paid, content, lifecycle. Prioritized roadmap tied to pipeline metrics. Delivered in 7 days.
Sprint-Based Execution
2-week sprint cycles. Real campaigns, not presentations. Each sprint ships measurable output across your priority channels.
Compounding Intelligence
AI agents monitor your channels 24/7. They catch budget waste, detect creative fatigue, track AI citation changes, and run A/B experiments autonomously. Week 12 is measurably better than week 1.
AI Marketing Operating System
3 elite humans + AI agents operating your growth system
Output multiplier: ~10x output at a fraction of the cost. The system gets smarter every week.
Month-to-month. Cancel anytime.
Common Questions
How does MH-1 differ from a marketing agency?
MH-1 pairs 3 elite human marketers with 7 AI agents. The humans handle strategy, creative direction, and judgment calls. The AI agents handle execution at scale: generating ad variants, monitoring competitors, building email sequences, tracking citations across LLMs, running A/B experiments autonomously. You get the quality of a senior marketing team with the output volume of a 15-person department.
What kind of results can we expect in the first 90 days?
First 90 days establish baseline: SEO audits clinical keyword gaps, AEO seeds LLM context, paid identifies top 30 hospital health systems by psychiatry spend and innovation budgets. Month two launches: SEO content targeting psychiatrists researching precision mental health, paid campaigns to hospital innovation leadership, founder thought leadership on clinical outcomes. Month three scales: lifecycle nurtures engaged hospital systems, content distributes Mount Sinai validation findings, competitive watch tracks Laguna Health and Senseye hospital partnerships. By day 90, expect measurable health system pipeline growth and clinician-level awareness lift.
How does AEO help hospitals discover your multimodal mental health AI.
AEO ensures that when clinicians, hospital innovation officers, and health system researchers ask LLMs about ambient AI for mental health monitoring, real-time pattern detection, or precision psychiatry tools, your multimodal approach and Mount Sinai validation appear prominently. This positions you against competitors and drives inbound clinical inquiry before sales outreach.
Can we cancel anytime?
Yes. MH-1 is month-to-month with no long-term contracts. We earn your business every sprint. That said, compounding effects kick in around month 3 as the AI agents accumulate data and the system learns what works for Deliberate AI specifically.
How is this page personalized for Deliberate AI?
This page was researched, audited, and generated using the same AI infrastructure we deploy for clients. The channel scores, team mapping, growth opportunities, and recommended agents are all based on real analysis of Deliberate AI's current marketing. This is a live demo of MH-1's capabilities.
Ambient multimodal AI needs health systems to find you
The system gets smarter every cycle. Let's talk about building it for Deliberate AI.
Book a Strategy CallMonth-to-month. Cancel anytime.